Smoking cessation

Código QR

Smoking cessation

Kirandeep Kaur, Shivani Juneja, Sandeep KaushalDepartment of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab, IndiaWith reference to the article published under the title &quot;Pharmacologic agents for smoking cessation: A clinical review&quot;,&nbsp;we...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kaur K, Juneja S, Kaushal S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Therapeutics. Pharmacology RM1-950
Acceso en línea:	https://doaj.org/article/e863becd9d664c50915f4f08ebfcb049
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Smoke Screen to Distract From Flawed Science: A Response to Côté et al. Over Criticisms to Their Deficient ‘Rapid Review’ on Chiropractic X-Ray Utility
por: Paul A. Oakley, et al.
Publicado: (2021)

The effect of smoking on the symptoms and progression of multiple sclerosis: a review
por: Afsaneh Shirani, et al.
Publicado: (2010)

Loading regimen required to rapidly achieve therapeutic trough plasma concentration of teicoplanin and evaluation of clinical features
por: Seki M, et al.
Publicado: (2012)

High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure
por: Yabuno K, et al.
Publicado: (2013)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine
por: Nanda K, et al.
Publicado: (2012)

Optimal management of Barrett&#39;s esophagus: pharmacologic, endoscopic, and surgical interventions
por: Konda VJA, et al.
Publicado: (2011)

Update on the management of ulcerative colitis: treatment and maintenance approaches focused on MMX&reg; mesalamine. [Corrigendum]
por: Nanda K, et al.
Publicado: (2013)

A Phase 1, randomized, open-label crossover study to evaluate the safety and pharmacokinetics of 400 mg albaconazole administered to healthy participants as a tablet formulation versus a capsule formulation
por: van Rossem K, et al.
Publicado: (2013)

The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies
por: Davies M, et al.
Publicado: (2016)

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report
por: Halka K, et al.
Publicado: (2011)

Clinical development of nintedanib for advanced non-small-cell lung cancer
por: Takeda M, et al.
Publicado: (2015)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven&reg;)
por: Bartosh NS, et al.
Publicado: (2013)

Severe iatrogenic bradycardia related to the combined use of beta-blocking agents and sodium channel blockers
por: Kawabata M, et al.
Publicado: (2015)

Pharmacokinetics and skin-tissue penetration of daptomycin in rats
por: Matsumoto K, et al.
Publicado: (2015)

Effects of irbesartan on serum uric acid levels in patients with hypertension and diabetes
por: Nakamura M, et al.
Publicado: (2014)

Bioavailability of everolimus administered as a single 5 mg tablet versus five 1 mg tablets: a randomized, open-label, two-way crossover study of healthy volunteers
por: Thudium K, et al.
Publicado: (2015)

Comparisons of Four Protein-Binding Models Characterizing the Pharmacokinetics of Unbound Phenytoin in Adult Patients Using Non-Linear Mixed-Effects Modeling
por: Heajin Jun, et al.
Publicado: (2020)

Symptomatic flexible flatfoot in adults: subtalar arthroereisis
por: Ozan F, et al.
Publicado: (2015)

Is hypertriglyceridemia a prognostic factor in sepsis?
por: Cetinkaya A, et al.
Publicado: (2014)

Vitexin as an active ingredient in passion flower with potential as an agent for nicotine cessation: vitexin antagonism of the expression of nicotine locomotor sensitization in rats
por: Samantha Bedell, et al.
Publicado: (2019)

Phase 1 clinical study of the acute and subacute safety and proof-of-concept efficacy of carbohydrate-derived fulvic acid
por: Janse van Rensburg CE, et al.
Publicado: (2012)

Arginine deprivation therapy for malignant melanoma
por: Yoon JK, et al.
Publicado: (2012)

Sedation in the intensive care setting
por: Hughes CG, et al.
Publicado: (2012)

Erratum
por: Barrese V, et al.
Publicado: (2012)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
por: Hashemi SN, et al.
Publicado: (2012)

Management of antipsychotic treatment discontinuation and interruptions using model-based simulations
por: Samtani MN, et al.
Publicado: (2012)

Interventions performed by community pharmacists in one Canadian province: a cross-sectional study
por: Young SW, et al.
Publicado: (2012)

Erratum
por: Samtani MN, et al.
Publicado: (2012)

Pazopanib for the treatment of soft-tissue sarcoma
por: Heudel P, et al.
Publicado: (2012)

Advances in the management of glioblastoma: the role of temozolomide and MGMT testing
por: Thomas RP, et al.
Publicado: (2012)

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
por: Li L, et al.
Publicado: (2012)

Population Pharmacokinetic Model of Plasma and Cellular Mycophenolic Acid in Kidney Transplant Patients from the CIMTRE Study
por: François Riglet, et al.
Publicado: (2020)

Modern approaches to pharmacotherapy of tuberculosis infection in children
por: Vasiliy E. Novikov, et al.
Publicado: (2021)

Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
por: Igor F. Belenichev, et al.
Publicado: (2021)

Is antibiotics overuse justified when immediate intervention is not possible? A rapid evidence review
por: Nour Ibrahim, et al.
Publicado: (2021)

Sodium Bicarbonate Nebulized Therapy in Patients with Confirmed COVID-19
por: Jalil Rashedi, et al.
Publicado: (2020)

A Debate on Vitamin C: Supplementation on the Hotline for Critically Ill Patients with COVID-19
por: Ata Mahmoodpoor, et al.
Publicado: (2020)

Book of Abstracts 38th Technology Days 9th and 10th September 2021
por: Molitorisová M.
Publicado: (2021)

Management of chronic hepatitis C virus infection in patients with end-stage renal disease: a review
por: Aguirre Valadez J, et al.
Publicado: (2015)

Atazanavir–bilirubin interaction: a pharmacokinetic–pharmacodynamic model [Corrigendum]
por: Lozano R, et al.
Publicado: (2013)